Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy

詳細情報 詳細情報について

• CRID

  1363107368985047424

• DOI

  10.1093/annonc/mdy055

• ISSN

  09237534

• Web Site

  https://api.elsevier.com/content/article/PII:S0923753419345296?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0923753419345296?httpAccept=text/plain

  http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdy055/23857195/mdy055.pdf

• データソース種別

  • Crossref